| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/22/2002 | WO2002064146A1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical |
| 08/22/2002 | WO2002064138A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 08/22/2002 | WO2002064126A2 Method of treating of demyelinating diseases or conditions |
| 08/22/2002 | WO2002064083A2 Synthesis of 3-amino-thalidomide and its enantiomers |
| 08/22/2002 | WO2002048112A3 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 08/22/2002 | WO2002044159A3 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence |
| 08/22/2002 | WO2002036587A3 Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides |
| 08/22/2002 | WO2002024221A3 Notch receptor agonists and uses |
| 08/22/2002 | WO2002020533A3 Benzoxazine alpha-1 adrenergic compounds |
| 08/22/2002 | WO2001093850A3 Methods and compositions using sulodexide for the treatment of diabetic nephropathy |
| 08/22/2002 | WO2001085204A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | WO2001085203A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | WO2000033865A9 Methods of inhibiting ectopic calcification |
| 08/22/2002 | US20020116069 Injectable implants for tissue augmentation and restoration |
| 08/22/2002 | US20020115856 Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g)indazole |
| 08/22/2002 | US20020115853 6-(3-nitrophenyl)-3H-benzooxazol-2-one for example; contraceptives, treating hormone dependent tumors, endometriosis; progesterone receptor agonists and antagonists |
| 08/22/2002 | US20020115833 Glycoprotein for use in the treatment of kidney and blood disorders |
| 08/22/2002 | US20020115702 Administering substituted imidazoles, particular by losartan potassium, treatment of post-transplant hypertension. |
| 08/22/2002 | US20020115697 Azabicyclic compounds used in treating a disease in the central nervous system caused by malfunctioning of the muscarinic cholinergic system. |
| 08/22/2002 | US20020115694 Methods for the treatment and prevention of urinary stone disease |
| 08/22/2002 | US20020115676 Therapy for andropause using estrogen agonists / antagonists and testosterone |
| 08/22/2002 | US20020115654 New compounds, their preparation and use |
| 08/22/2002 | US20020115156 Connective tissue growth factor for use in the treatment of cancer, fibrotic defects and atherosclerosis; for use as wound healing agents |
| 08/22/2002 | US20020115090 Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 08/22/2002 | US20020114841 Composition and method |
| 08/22/2002 | US20020114801 Heparanase specific molecular probes and their use in research and medical applications |
| 08/22/2002 | DE10107639A1 2-Alkoxyphenyl-substituierte Imidazotriazinone 2-alkoxy-phenyl-substituted imidazotriazinones |
| 08/22/2002 | DE10055857A1 Neue pharmazeutische Depotformulierung New pharmaceutical depot formulation |
| 08/22/2002 | CA2856986A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | CA2666611A1 Novel succinate salt of o-desmethyl-venlafaxine |
| 08/22/2002 | CA2438712A1 Method of treating of demyelinating diseases or conditions |
| 08/22/2002 | CA2438590A1 Therapeutic methods and agents for diseases associated with decreased expression of aop-1 gene or aop-1 |
| 08/22/2002 | CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | CA2438153A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | CA2438113A1 2-alkoxyphenyl substituted imidazotriazinones |
| 08/22/2002 | CA2437809A1 Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence |
| 08/22/2002 | CA2437358A1 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | CA2436195A1 Laulimalide derivatives |
| 08/22/2002 | CA2431033A1 Crystallization of igf-1 |
| 08/21/2002 | EP1233015A1 Use of imidazole derivatives for the treatement of deseases involving the AT1 and AT2s receptors of angiotensine, some of these products, their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 08/21/2002 | EP1232150A1 Urea derivatives as anti-inflammatory agents |
| 08/21/2002 | EP1232147A1 Triazoles as farnesyl transferase inhibitors |
| 08/21/2002 | EP1232144A2 Novel il-8 receptor antagonists |
| 08/21/2002 | EP1232141A1 Ethers of o-desmethyl venlafaxine |
| 08/21/2002 | EP1231982A2 Use of phthalazine derivatives |
| 08/21/2002 | EP1231940A1 Stable amorphous amifostine composition, and preparation thereof |
| 08/21/2002 | EP1231916A2 Use of indirubine derivatives for making medicines |
| 08/21/2002 | EP0771192B1 Use of anti-vegf agents in the treatment of endometriosis |
| 08/21/2002 | CN1365363A thineopyranecarboxyamide derivatives |
| 08/21/2002 | CN1365284A Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 08/21/2002 | CN1364637A Medicament for curing prostatic urinary diseases |
| 08/21/2002 | CN1364554A Nano Long eliminating medicine and its preparing method |
| 08/21/2002 | CN1364540A Nano Herba Artemisiae scopariae and five drugs medicine and its preparing method |
| 08/21/2002 | CN1364528A Nano nephritis treating medicine and its preparing method |
| 08/21/2002 | CN1364508A nano seven flavor Duqi medicine and its preparing method |
| 08/21/2002 | CN1364475A Nano five stranguria treating medicine and its preparing method |
| 08/21/2002 | CN1089246C Medicament for treating urinary calculus and its preparation method |
| 08/21/2002 | CN1089245C Soy extract, process for its prepn. and pharmaceutical compsn. |
| 08/20/2002 | US6437177 α-hydroxy, -amino, and halo derivatives of β-sulfonyl hydroxamic acids as matrix metallopropteinases inhibitors |
| 08/20/2002 | US6437165 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 08/20/2002 | US6437146 Mesangial proliferative glomerulonephritis |
| 08/20/2002 | US6437137 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 08/20/2002 | US6437111 Bone morphogenetic protein-11 (BMP-11) compositions |
| 08/20/2002 | US6437094 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 08/20/2002 | US6436997 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 08/20/2002 | US6436977 Dosing regimens for lasofoxifene |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436962 Alpha 1a adrenergic receptor antagonists; relief from benign prostatic hyperplasia by less hindered urine flow by relaxing smooth muscle tissue; with a testosterone 5-alpha reductase inhibitor, finasteride; acute and chronic relief |
| 08/20/2002 | US6436925 Better able to cross membranes; inhibitors of cysteine proteases like calpain i and ii and cathepsin b and l, can thus be used to control diseases associated with an elevated activity of calpain enzymes or cathepsin enzymes |
| 08/20/2002 | US6436923 Compounds and methods for modulation of estrogen receptors |
| 08/20/2002 | US6436911 IL-12 production inhibitor |
| 08/20/2002 | US6436909 Antisense inhibition of transforming growth factor-β expression |
| 08/20/2002 | US6436394 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 08/20/2002 | US6436388 Method of treating rhabdomyolysis by administering hepatocyte growth factor |
| 08/20/2002 | CA2240138C Quinazolin-4-one ampa antagonists |
| 08/15/2002 | WO2002063010A2 Method of producing recombinant antibodies against tumors |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002062972A2 Hybridoma cell line g250 and its use for producing monoclonal antibodies |
| 08/15/2002 | WO2002062840A1 INTERFERON-α INDUCED GENE |
| 08/15/2002 | WO2002062804A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | WO2002062800A1 Bicyclic nitrogenous fused-ring compound |
| 08/15/2002 | WO2002062799A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | WO2002062798A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | WO2002062794A2 Compounds |
| 08/15/2002 | WO2002062793A1 Thiazole compounds as tgf-beta inhibitors |
| 08/15/2002 | WO2002062792A1 Jnk inhibitor |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062788A1 Sulfonamide compounds, their preparation and use |
| 08/15/2002 | WO2002062787A1 Pyrazoles as tgf inhibitors |
| 08/15/2002 | WO2002062777A2 Amino ceramide-like compounds and therapeutic methods of use |
| 08/15/2002 | WO2002062762A2 Potassium channel openers |
| 08/15/2002 | WO2002062761A1 Aminal diones as potassium channel openers |
| 08/15/2002 | WO2002062751A1 Novel cystine derivatives and inhibitors for the activation of inflammatory factors |
| 08/15/2002 | WO2002062750A1 Cannabinoid receptor ligands |
| 08/15/2002 | WO2002062745A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 08/15/2002 | WO2002062390A1 Medicinal compositions for treating lower uropathy |
| 08/15/2002 | WO2002062389A1 Remedies for urinary diseases comprising lpa receptor controlling agents |
| 08/15/2002 | WO2002062343A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS |
| 08/15/2002 | WO2002062337A1 Thiazolidinediones |
| 08/15/2002 | WO2002062330A2 Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |